US biotech MaxCyte chooses London for IPO
US biotech firm MaxCyte started trading on London’s junior stock exchange on Tuesday, after raising £10m from its initial public offering.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: